Asia Stocks: Australia Boosted by BHP, Japan Extends Losses on Soft GDP (Feb. 16, 2026)

 

# Asia Stocks: Australia Boosted by BHP, Japan Extends Losses on Soft GDP (Feb. 16, 2026)

## A Tale of Two Economies: Mining Magnates vs. Economic Drag

**Published: Tuesday, February 17, 2026 – 9:00 AM EST**

The Asian trading session on Monday, February 16, presented a starkly divided picture, painting a perfect portrait of how local catalysts can drive markets in opposite directions even during a holiday-shortened, low-volume trading day .

On one side of the Pacific Rim, the **Australian sharemarket celebrated a historic milestone**, propelled to a record high by the stellar performance of its largest company, global mining titan BHP Group . The S&P/ASX 200 climbed, fueled by BHP's blockbuster earnings report which highlighted a significant strategic shift towards copper and rewarded shareholders handsomely .

On the other side, the mood in Tokyo was decidedly more somber. **Japan's Nikkei 225 index extended its losing streak to four days**, succumbing to selling pressure following the release of shockingly weak economic growth data for the fourth quarter of 2025 . The numbers underscored the fragility of Japan's domestic demand and raised new questions about the pace of future central bank policy moves .

This analysis dives deep into the key drivers of Monday's Asian market action, providing a comprehensive look at the BHP-led rally in Australia, the GDP-induced slump in Japan, and the broader regional context that U.S. investors need to understand.

---

## The Keyword Goldmine: What America Is Searching for Right Now

A divergence in two major Asian economies creates a wealth of high-intent search queries from investors seeking to understand global macro trends. Here are the most valuable keyword clusters emerging from this market action.

**Table 1: High-Value Keyword Clusters – Asia Markets & Commodities (Feb. 2026)**

| **Keyword Cluster Theme** | **Sample High-Value, Lower-Competition Keywords** | **Commercial Intent & Advertiser Appeal** |

| :--- | :--- | :--- |

| **Commodity & Mining Stocks** | "BHP stock analysis 2026 dividend", "copper price forecast 2026 demand AI", "Rio Tinto earnings preview 2026", "Fortescue iron ore outlook" | **Extremely High.** Targets investors looking for exposure to commodities. Advertisers: Online brokerages (Fidelity, Schwab), commodity trading platforms, mining ETFs. |

| **Japan Macro & Nikkei Trading** | "Nikkei 225 live chart 2026", "Japan GDP impact on BOJ rate hike", "Japanese yen USDJPY forecast 2026", "Topix index sector performance" | **Very High.** Targets forex traders and macro hedge funds. Advertisers: Forex brokers, international stock brokers (Interactive Brokers), economic research subscriptions. |

| **Global Growth Indicators** | "IMF global growth forecast 2026", "India GDP vs China growth", "coincident economic indicators list", "trade deficit impact on currency" | **High.** Targets sophisticated macro investors. Advertisers: Economic data platforms (Bloomberg Terminal), geopolitical risk consultancies, investment newsletters. |

| **Australia Interest Rates** | "RBA rate hike odds 2026", "Australia inflation data 2026", "RBA meeting minutes analysis", "Australian dollar AUDUSD forecast" | **High.** Targets forex traders and bond investors. Advertisers: Currency hedging services, international bond brokers, Australian bank ADRs. |

| **China & Lunar New Year Impact** | "Lunar New Year trading hours 2026", "China markets reopen date 2026", "Hang Seng index outlook February", "Alibaba stock news February 2026" | **Moderate-High.** Investors waiting for Chinese markets to reopen. Advertisers: China-focused ETFs, Hong Kong stock brokers, emerging market funds. |

---

## Part 1: Australia's Lucky Country Moment – BHP Smashes Records

While much of Asia observed the Lunar New Year holiday, the Australian market was very much open for business, and it delivered a performance worthy of the celebration .

### BHP's Historic Half: Copper Takes the Crown

The undisputed star of the session was **BHP Group (ASX: BHP)** , the world's largest listed miner. The company reported its first-half results for fiscal year 2026, and the numbers were nothing short of spectacular .

**Table 2: BHP 1H26 Earnings – Key Highlights vs. Expectations**

| **Metric** | **1H26 Actual** | **YoY Growth** | **vs. Estimates** | **Significance** |

| :--- | :--- | :--- | :--- | :--- |

| **Revenue** | $27.9 Billion | +11% | 2% Beat | Driven by record copper and iron ore prices  |

| **Underlying EBITDA** | $15.5 Billion | +25% | 3% Beat | Reflects operational efficiency and higher margins  |

| **Profit from Operations** | $12.3 Billion | +34% | 3% Beat | Strong performance across the board  |

| **Interim Dividend** | **US$0.73 / share** | +44% | 5.7% Beat | A huge cash return for shareholders  |

| **Copper's Share of EBITDA** | **51%** | N/A | Milestone | Copper earnings surpass iron ore for the first time  |

The headline numbers are impressive, but the strategic inflection point is even more significant. For the first time in its long history, **copper contributed the largest share of BHP's overall earnings**, accounting for 51% of Underlying EBITDA . This cements BHP's transformation into the world's premier copper producer, a position of immense value in an era of electrification and AI-driven data center build-out.

CEO Mike Henry highlighted this milestone, noting the "strong performance at Escondida" and solid contributions from operations in Chile and South Australia . The company even upgraded its full-year copper production guidance, signaling confidence in sustained demand.

### The Market's Reaction: A Stampede into BHP

The market's verdict was immediate and decisive. BHP shares **surged as much as 7.0% in early trade**, reaching an all-time high of A$53.90 . By the close, the stock was up over 4.7%, making it one of the top performers on the ASX 200 and a primary driver of the index's 0.24% gain .

**Table 3: Market Impact – S&P/ASX 200 on Feb. 16, 2026**

| **Metric** | **Performance** | **Details** |

| :--- | :--- | :--- |

| **S&P/ASX 200 Index** | **+0.24%** (to 8,958.90) | Lifted almost single-handedly by BHP  |

| **BHP Group (BHP)** | **+4.73%** (to record A$52.74) | Best day since March 2020; YTD returns ~20%  |

| **Materials Sector** | **+1.28%** | Best-performing sector of the day  |

| **Financials Sector** | **Little changed** | Profit-taking after recent earnings-driven rally  |

**What drove the price action?** The 44% dividend hike was a major catalyst, returning significant cash to shareholders at a payout ratio of just 60%, suggesting room for future increases . Furthermore, the company announced a strategy to unlock up to **US$10 billion in capital** through non-core asset sales, including a silver streaming deal and infrastructure partnerships, to fund future copper expansion projects . This "portfolio funding" approach signals disciplined capital allocation, a trait highly prized by investors.

### The RBA Context: Inflation Still a Concern

The rosy picture from corporate Australia was tempered slightly by the release of the Reserve Bank of Australia's (RBA) February meeting minutes. Policymakers indicated that inflation would have remained "too high" without this month's rate hike and flagged uncertainty over whether further tightening would be needed . For U.S. investors, this reinforces a global theme: while commodity giants boom, central banks remain vigilant against sticky inflation.

---

## Part 2: Japan's GDP Shock – The Nikkei's Four-Day Slide

If Australia was the party, Japan was the hangover. The Nikkei 225 index fell for a fourth consecutive session, closing down **0.24% at 56,806.41**, while the broader Topix index suffered a steeper decline of 0.82% .

### The GDP Miss: Anemic Growth in Q4

The trigger for the sell-off was the Cabinet Office's release of fourth-quarter GDP data, which painted a picture of an economy struggling to gain traction.

**Table 4: Japan Q4 2025 GDP – Actual vs. Expectations**

| **Metric** | **Actual** | **Market Forecast** | **Miss** | **Details** |

| :--- | :--- | :--- | :--- | :--- |

| **GDP (Quarter-on-Quarter)** | +0.1% | +0.4% | **Significant** | Barely positive after a Q3 contraction  |

| **GDP (Annualized)** | **+0.2%** | **+1.6%** | **Massive Miss** | Shows extreme underlying weakness  |

| **Private Consumption** | +0.1% | N/A | Weak | Households still squeezed by inflation  |

| **Capital Spending** | +0.2% | N/A | Tepid | Businesses remain cautious  |

This was not just a small miss; it was a catastrophic one. An expected annualized growth rate of 1.6% would have signaled a healthy rebound. The actual 0.2% figure suggests an economy that is essentially stagnant .

**What went wrong?** Analysts pointed to several factors:

1.  **Weak Business Spending:** Despite government incentives, capital investment remained sluggish .

2.  **Sluggish Export Demand:** The global manufacturing slowdown and China's uneven recovery weighed on exports .

3.  **Fragile Consumption:** Japanese households continue to grapple with inflation that has hovered above the BOJ's 2% target for four straight years. Real wages remain negative, squeezing purchasing power .

4.  **Tourism Slowdown:** A diplomatic spat with China led to a slump in Chinese visitors, impacting service exports .

### The Takaichi Factor: More Stimulus on the Way?

The weak GDP data has immediate political implications. Prime Minister Sanae Takaichi, fresh off a historic election victory, now has a powerful argument for her expansionary fiscal policies .

The data "may embolden PM Takaichi to press ahead with even more fiscal loosening," noted Marcel Thieliant at Capital Economics . This could include her controversial pledge to temporarily suspend the sales tax on food and potentially enact another supplementary budget sooner than anticipated .

**For investors, this is a double-edged sword.** More stimulus could boost growth in the short term, but Japan's debt-to-GDP ratio is already the highest in the developed world, and bond yields have been rising on concerns about fiscal sustainability .

### BOJ Implications: A Hike Still on the Table?

Despite the weak growth, most economists believe this data will not derail the Bank of Japan from its path of gradual interest rate hikes later in the year . Inflation remains sticky, and the BOJ is focused on normalizing policy after decades of unprecedented easing.

However, the weak Yen (trading around 153 to the USD) and its impact on import costs remain a key variable for the central bank to manage .

---

## Part 3: The Broader Regional Picture – Holiday Lull and Tech Jitters

Beyond the headline acts in Australia and Japan, the rest of the Asian region was characterized by thin, holiday-muted trading .

### Lunar New Year Closures

Markets in **Mainland China, South Korea, and Taiwan** were closed for the entirety of Monday in observance of the Lunar New Year holiday . Hong Kong's Hang Seng Index managed a **0.5% gain in a half-day session** before closing for its own multi-day holiday .

### The Lingering AI Cloud

The muted volumes also reflected a cautious undertone carried over from Wall Street the previous week. Fears about the disruptive impact of **Artificial Intelligence (AI) on specific industries**, particularly software, continued to simmer . While Friday's cooler-than-expected U.S. CPI data provided some relief, the broader uncertainty about AI's winners and losers kept a lid on risk appetite .

### What's on the Horizon?

U.S. investors should keep an eye on the following catalysts as the week progresses:

- **U.S. Data:** The market is awaiting the FOMC meeting minutes, GDP revisions, and the PCE inflation data for cues on the Fed's next move .

- **Australian Jobs Data:** Due on Thursday, this will be a key read on the country's labor market and future RBA decisions .

- **Commodity Earnings:** Rio Tinto reports on Thursday, and Fortescue next week. Investors will watch for signals on iron ore demand, especially from China .

---

## FREQUENTLY ASKED QUESTIONS (FAQs)

**Q1: Why did Australian stocks rise while Japanese stocks fell on February 16?**

**A:** This divergence was driven by local catalysts. Australian stocks were boosted by a **historic earnings report from mining giant BHP**, which posted record profits and a massive dividend increase, lifting the entire materials sector . Conversely, Japanese stocks tumbled after the government reported **fourth-quarter GDP growth that was dramatically weaker than expected**, highlighting the fragility of the economic recovery .

**Q2: What was so special about BHP's earnings report?**

**A:** BHP's first-half results showed a **25% jump in underlying EBITDA** and a **44% increase in the dividend** . Most importantly, for the first time ever, **copper contributed more than half of the company's earnings**, surpassing iron ore. This signals BHP's successful pivot to becoming a major player in the metals critical for electrification and AI infrastructure .

**Q3: How weak was Japan's GDP, and why does it matter for U.S. investors?**

**A:** Japan's economy grew at an annualized rate of just **0.2% in Q4 2025**, compared to market forecasts of 1.6% . This matters for U.S. investors because Japan is a major economy and a key trading partner. Persistent weakness could impact global supply chains and demand. Furthermore, it creates policy dilemmas for the Bank of Japan, influencing the Yen (USDJPY) and global bond markets .

**Q4: Were any other Asian markets open and trading?**

**A:** Trading was very thin across the region. Major markets like **Mainland China, South Korea, and Taiwan were closed for the Lunar New Year holiday** . Hong Kong had a half-day session, ending slightly higher .

**Q5: How did U.S. market trends influence Asia on this day?**

**A:** The holiday-thinned trading in Asia meant that markets were somewhat insulated from, but still mindful of, the previous week's trends on Wall Street. Concerns over the **disruptive potential of AI on certain business models** lingered in the background, contributing to a cautious tone . However, Friday's softer U.S. inflation data provided some underlying support .

**Q6: What is the outlook for BHP's stock after its record high?**

**A:** BHP's strong results, strategic focus on copper, and commitment to returning capital to shareholders (via dividends) have created a very positive outlook . However, investors should watch the outcome of iron ore contract negotiations with China and monitor global commodity demand. The company is using asset sales to fund growth, a disciplined approach that markets generally favor .

**Q7: Will the weak Japanese GDP force the Bank of Japan to stop raising interest rates?**

**A:** Most economists think **it will not derail the BOJ's gradual rate hike path** . While growth is weak, inflation remains above the BOJ's target. The central bank is focused on normalizing policy after decades of stimulus, though the weak data gives them reason to proceed cautiously .

**Q8: What should I watch for next in these markets?**

**A:** Key items include:

- **Australia:** Thursday's jobs data for clues on the RBA's next move .

- **Japan:** Any announcements from PM Takaichi regarding new fiscal stimulus measures .

- **Commodities:** Earnings reports from Rio Tinto and Fortescue for signals on iron ore demand .

- **U.S. Data:** The FOMC minutes and PCE inflation report will set the global risk tone .

---

## CONCLUSION: A Continent of Contrasts

Monday's trading session in Asia was a powerful reminder that "Asia" is not a monolith. It is a collection of distinct economies, each responding to its own unique drivers.

In **Australia**, we witnessed the power of a corporate champion. BHP's results were not just good; they were transformative, signaling a strategic shift towards the metals of the future. This fueled a record-breaking rally that shrugged off broader central bank concerns . For investors, it underscores the value of looking at commodities and materials as a potential hedge and growth area.

In **Japan**, we were reminded of the persistent structural challenges facing the world's fourth-largest economy. The GDP data was a cold splash of water, revealing an economy that remains stubbornly reliant on stimulus and vulnerable to external shocks . The market's negative reaction reflects a fear that the "good times" of corporate reform and mild inflation may not be enough to overcome deep-seated demographic and demand-side weakness.

For the American investor, the takeaway is clear: **global diversification requires active attention.** While the S&P 500 might be hitting its own milestones, the forces moving markets in Sydney and Tokyo are fundamentally different. Understanding these local catalysts—a mining giant's earnings, a political leader's stimulus pledge, or a central bank's data-dependent dilemma—is the key to navigating the complex and often contradictory world of international investing.

The holiday lull may have muted trading volumes, but it could not mask the powerful economic narratives unfolding across the Pacific.

---

*This article is for informational purposes only and does not constitute investment advice. Always conduct your own research and consult with a qualified financial professional before making investment decisions.*

**About the author:** This analysis synthesizes reporting from Market Index, Reuters, RTE.ie, Xinhua, The Asahi Shimbun, The Economic Times, NDTV Profit, and other sources cited throughout. All sources are available for independent verification.

**Disclosure:** The author holds no direct positions in the securities mentioned (BHP, RIO, FMG) at the time of publication. Positions may change without notice. This article contains no affiliate links.

Finally Some Good News on Drug Prices: Novo Nordisk Slashes Wegovy and Ozempic Costs Up to 50%

 

# Finally Some Good News on Drug Prices: Novo Nordisk Slashes Wegovy and Ozempic Costs Up to 50%

**Published: February 24, 2026**

You know how every time you turn on the news, there's another story about something getting more expensive? Groceries, rent, gas—it never seems to stop.

Well, today we actually got some good news for a change.

Novo Nordisk just announced they're cutting the list price of their blockbuster drugs Wegovy and Ozempic by as much as 50% starting next year . For people with certain types of insurance, this could mean real savings at the pharmacy counter.

Let me break down what just happened, why it matters, and whether this is actually as good as it sounds.

---

## The Short Version

**What happened:** Novo Nordisk announced they're dropping the monthly list price of Wegovy, Ozempic, and Rybelsus to a flat **$675** starting January 1, 2027 .

**How much are we talking?** Wegovy is getting cut 50% from its current $1,349 price. Ozempic drops 34% from $1,027 .

**Who benefits most?** People with high-deductible health plans or coinsurance where you pay a percentage of the list price .

**Who doesn't benefit?** If you're paying cash through those direct-to-consumer portals, nothing changes .

**What happened to the stocks?** Novo Nordisk shares fell about 3%, and rival Eli Lilly dropped 2% .

---

## The Details: What's Actually Changing

Let's get specific about the numbers, because this is where it gets interesting.

**Table 1: Novo Nordisk Price Cuts (Effective Jan 2027)**

| **Drug** | **Current List Price** | **New List Price** | **Reduction** |

| :--- | :--- | :--- | :--- |

| Wegovy (injection) | $1,349.02 | $675 | 50% |

| Wegovy (pill) | $1,349.02 | $675 | 50% |

| Ozempic (injection) | $1,027.51 | $675 | 34% |

| Rybelsus (pill) | $1,027.51 | $675 | 34% |

*Source: Bloomberg *

The new price applies to all the common doses: Wegovy 2.4 mg injection and 25 mg tablets, Ozempic 0.5 mg, 1 mg, and 2 mg injections, and Rybelsus 7 mg and 14 mg tablets .

**Jamey Millar**, Novo's EVP of U.S. operations, explained the thinking: "The lower list price is intended to connect more people with our innovative medicines, specifically those whose out-of-pocket costs are linked to list price, such as individuals with high-deductible health plans or co-insurance benefit designs" .

---

## Wait, What's "List Price" vs. What People Actually Pay?

This is the part that trips everyone up. The "list price" (technically called wholesale acquisition cost) is not what most people pay.

Here's how it usually works:

**If you have good insurance:** You might pay a flat copay of $25 or $30, regardless of the list price. The insurance company and pharmacy benefit manager negotiate rebates and discounts behind the scenes.

**If you have a high-deductible plan:** You pay the full negotiated price until you hit your deductible. That's where list price matters—because if you're paying 100% until you meet that $3,000 or $5,000 deductible, a $675 price tag is a lot easier to swallow than $1,349.

**If you have coinsurance:** Some plans make you pay a percentage of the drug cost—say 20%. If the list price drops from $1,349 to $675, your 20% drops from $270 to $135.

**If you're on Medicare:** This doesn't affect you directly. Medicare already negotiated lower prices—Ozempic will be $274 for Medicare patients starting next year .

**If you're paying cash through Novo's direct program:** Nothing changes. The self-pay prices stay the same .

About a third of workers with employer-sponsored insurance are in high-deductible plans, according to KFF data . That's a lot of people who could see real savings.

---

## Why Is Novo Doing This?

Here's where the story gets interesting. This isn't just corporate kindness. There's some serious competition heating up.

**Eli Lilly has been eating Novo's lunch.** Their drug Zepbound (the obesity version) and Mounjaro (diabetes) are just... better. A head-to-head trial showed Lilly's tirzepatide helped people lose more weight than Novo's semaglutide . And doctors are prescribing Lilly's drugs more.

**The numbers tell the story:** Novo's stock has tumbled 25% so far this year. Lilly's shares are down just 2% . Novo warned last week that 2026 sales could drop 5% to 13% . Lilly, meanwhile, is projecting 25% growth .

**Novo's new drug CagriSema didn't wow anyone.** They announced Monday that it didn't work as well as Zepbound in trials . That's a big blow to their pipeline.

**The pill competition is coming.** Novo just launched the first GLP-1 pill for weight loss—Wegovy tablets—and it's been called the "fastest launch ever" . But Lilly's oral drug orforglipron is coming later this year, and it might be more convenient (no weird rules about drinking water and waiting 30 minutes to eat) .

So Novo is pulling the pricing lever to stay competitive. Millar, their U.S. chief, came from UnitedHealth's pharmacy benefit manager Optum Rx. He knows exactly how this system works .

---

## What About Lilly? Are They Next?

Lilly's stock dipped 2% on the news . That makes sense—if Novo lowers prices, Lilly might feel pressure to do the same.

But here's the thing analysts are saying: **this might not hurt Lilly as much as you'd think.**

Bank of America reiterated their "buy" rating on Lilly with a $1,293 price target . Their logic? The price cuts only apply to commercial insurance, which is a shrinking piece of the GLP-1 market. The real growth is in Medicare (which has its own prices) and cash pay .

Also, Lilly's drugs are just... better. When you have a superior product, you don't have to compete as hard on price.

**Zepbound's current list price?** $1,086.37 . So Novo's $675 Wegovy is now significantly cheaper on paper. But again, list price isn't what most people pay.

---

## The Bigger Picture: What This Says About the GLP-1 Market

This move tells us something important about where this whole industry is headed.

**The gold rush is maturing.** These drugs have been printing money for years. Wegovy, Ozempic, Zepbound, Mounjaro—they're basically the most successful class of drugs in history. But as competition heats up, pricing power fades.

**Volume over margin.** Novo is betting that lower prices will mean more insured patients get covered. Right now, less than half of large companies cover Wegovy for weight loss . If lower list prices make insurers happier, more people get access, and Novo sells more pills.

**The cash market is growing.** Novo and Lilly have both started selling directly to patients through programs like NovoCare Pharmacy. That bypasses the whole insurance mess. Those prices aren't changing .

**Medicare is now in the game.** Thanks to those deals with the Trump administration last year, Medicare will start covering obesity drugs by July . That's 40 million new potential patients. The Medicare price for Ozempic? $274 . Way below even the new $675 list price.

---

## What This Means for You

Okay, so how does this actually affect your life?

### If You Have Wegovy or Ozempic Prescribed

First, nothing changes until January 2027. That's almost a year away.

If you're in a high-deductible plan or pay coinsurance, this could be real money. Run the numbers when your plan renews next year. Your out-of-pocket costs might drop significantly.

If you have good insurance with flat copays, you probably won't notice a difference.

### If You've Been Thinking About Trying These Drugs

This might be a reason to wait until 2027—but also might not. The access problem isn't just about price. It's about whether your insurance covers weight loss drugs at all. That's still a huge barrier.

Also, these drugs are still in short supply for some doses. That's getting better, but it's not solved.

### If You're on Medicare

You're already getting a better deal. The Medicare negotiated prices kick in next year too, and they're lower than even these new list prices .

### If You're an Investor

This is a reminder that the GLP-1 market is getting crowded. Novo is playing defense. Lilly is playing offense. The pill versions coming later this year could shake things up even more.

Analysts still like Lilly better. But both companies are in a massive, growing market. The question is who captures more of it.

---

## Frequently Asked Questions

**Q: When do these price cuts take effect?**

A: January 1, 2027 . The company announced now so insurers and pharmacy benefit managers have time to adjust their formularies.

**Q: Will my out-of-pocket costs definitely go down?**

A: Not necessarily. It depends on your insurance. If you have a high-deductible plan or coinsurance, probably yes. If you have flat copays, probably not .

**Q: Does this affect the cash price if I pay through Novo's direct program?**

A: No. The self-pay prices through NovoCare Pharmacy and other direct channels are staying the same .

**Q: What about Medicare patients?**

A: Medicare already negotiated lower prices—Ozempic will be $274 for Medicare patients starting next year . Those aren't changing.

**Q: Is Eli Lilly going to cut their prices too?**

A: They haven't announced anything. Analysts think the impact on Lilly is limited because their drugs are more effective and their business mix is different . But competition is competition.

**Q: Why is Novo doing this now?**

A: A few reasons: they're losing market share to Lilly, their next-gen drug didn't perform as hoped, and they need to make insurers happier to get broader coverage .

**Q: Will this make these drugs easier to get?**

A: Possibly. If lower list prices make insurers more willing to cover weight loss drugs, more people could get access. That's part of the hope .

**Q: What about the pill versions?**

A: The Wegovy pill (25 mg tablets) is included in the price cut. Rybelsus, the diabetes pill, is too . Lilly's oral drug isn't out yet, so no word on their pricing.

**Q: Is this related to the Trump administration drug pricing deals?**

A: Not directly. Novo says these two things aren't linked . But they happen at the same time, so it's all part of the same pressure on drug prices.

---

## The Bottom Line

Here's what I keep coming back to.

For years, we've watched drug prices go up and up and up. Every negotiation, every reform, every promise—and prices kept climbing.

Today, one of the biggest drug companies in the world announced they're cutting prices on their most popular products. Voluntarily. By a lot.

**The reason isn't charity.** It's competition. Lilly's better drugs are eating Novo's lunch. The pill market is heating up. Insurers are pushing back. Medicare is finally negotiating.

But you know what? I don't really care why they're doing it. I care that it's happening.

For people with high-deductible plans—which is about a third of workers—this could mean hundreds of dollars a month in savings. For people who've been priced out of these drugs, it might finally make them affordable.

**Jamey Millar**, Novo's U.S. chief, said something interesting: "Private and public payers, as well as patients, want access and have been calling for lower list prices" .

They've been calling for years. Now, finally, someone answered.

Will it be enough? Probably not for everyone. There are still millions of people who need these drugs and can't get them. Insurance coverage is still spotty. Supply is still tight.

But it's a start. It's movement in the right direction. And after years of watching drug prices only go up, that's worth noticing.

---

*Got questions about how this affects your specific situation? Drop them in the comments. If you're on one of these drugs, I'd love to hear what you're paying now and whether this changes anything for you.*

Home Depot Just Dropped Its 2025 Numbers: A Tiny Dividend Hike and a Cautious Look Ahead

 

# Home Depot Just Dropped Its 2025 Numbers: A Tiny Dividend Hike and a Cautious Look Ahead

**Published: February 24, 2026**

You know that feeling when you walk into Home Depot on a Saturday morning, and the place is buzzing? Carts everywhere, folks loading up lumber, that orange apron walking you to the exact aisle you need?

The numbers they just released tell a slightly different story. A quieter one.

Home Depot reported their fourth quarter and full year 2025 results today . Sales were down a bit. Profits were down a bit. But here's the thing—they still beat what Wall Street expected . And they're giving shareholders a tiny little raise on that dividend.

Let me walk you through what this all means in plain English.

---

## The Short Version

**What happened:** Home Depot's Q4 sales dropped to $38.2 billion, down 3.8% from last year . But that's a little misleading—last year's quarter had an extra week, which added about $2.5 billion in sales . Strip that out, and their comparable sales actually grew 0.4% .

**The bottom line:** Net earnings were $2.6 billion, or $2.58 per share. Adjusted earnings came in at $2.72 per share—better than the $2.53 analysts were expecting .

**The dividend:** They bumped it up 1.3% to $2.33 per share quarterly, which works out to $9.32 a year . It's not huge, but it's the 156th quarter in a row they've paid one .

**What's next:** For 2026, they're guiding for sales growth between 2.5% and 4.5%, and earnings per share to be flat to up 4% .

---

## The Numbers: Let's Break It Down

Here's the full picture of what Home Depot just reported.

**Table 1: Home Depot Q4 2025 vs. Expectations**

| **Metric** | **Actual** | **What Analysts Expected** | **Vs. Last Year** |

| :--- | :--- | :--- | :--- |

| Revenue | $38.2 billion | $38.09 billion  | Down 3.8% |

| Adjusted EPS | $2.72 | $2.53  | Down 13% |

| Comparable Sales | +0.4% | Slightly negative  | Improved |

| U.S. Comps | +0.3% | N/A | Improved |

Now, that 3.8% revenue drop looks scary until you understand the calendar. Last year's Q4 had 14 weeks. This year's had 13. That extra week last year accounted for about $2.5 billion in sales and about 30 cents per share in earnings . So on a comparable basis, they actually grew a little.

**Ted Decker**, Home Depot's CEO, put it this way: "For the fourth quarter, our results were largely in-line with our expectations, reflecting the lack of storm activity in the third quarter and ongoing consumer uncertainty and pressure in housing" .

See that bit about storms? It matters. Normally, Home Depot gets a boost when hurricanes hit—people need plywood, generators, chain saws. That didn't happen much in late 2025. But Winter Storm Fern in January did give them a little bump .

---

## The Full Year Picture

For all of fiscal 2025, here's how it shook out.

**Table 2: Home Depot Fiscal 2025 Results**

| **Metric** | **Fiscal 2025** | **Change** |

| :--- | :--- | :--- |

| Total Sales | $164.7 billion | +3.2%  |

| Comparable Sales | +0.3% | Slightly positive |

| U.S. Comps | +0.5% | Positive |

| Net Earnings | $14.2 billion | Down from $14.8 billion |

| Adjusted EPS | $14.69 | Down from $15.24 |

So sales grew, but profits shrank a bit. That's the story of retail right now—higher costs, cautious customers, and everyone waiting to see what happens with interest rates and the housing market.

Decker said underlying demand was "relatively stable throughout the year," once you adjust for the lack of storms .

---

## The Dividend: Small but Steady

Here's something you don't see every day: a company raising its dividend by 1.3%.

It's tiny. Almost comically tiny. But it's also the 156th consecutive quarterly dividend Home Depot has paid . That's 39 years.

**The new payout:** $2.33 per share quarterly, or $9.32 annually . Based on Monday's closing price of $376.99, that's a yield of about 2.47% .

The dividend is payable March 26 to shareholders of record on March 12 .

**Why so small?** Because companies don't like cutting dividends. They'd rather raise them a penny than raise them a dime and have to take it back later. This tiny increase says "we're confident enough to give you a little more, but cautious enough not to overpromise."

---

## What's Happening With Customers

This is where it gets interesting. The numbers tell a story about how people are shopping right now.

**Transactions dropped 8.5%** . That means fewer people walking through the doors or checking out online.

**But the average ticket rose 2.4%** . So the people who are shopping are spending more each time.

What does that tell you? People are doing the stuff they have to do—fixing the leaky faucet, patching the drywall, replacing the broken water heater. They're not doing the big discretionary projects—the kitchen remodel, the bathroom renovation, the deck addition.

**Finimize** called it a "classic 'fix what you must' mix" . And that's exactly right.

**The housing market is the culprit.** High interest rates mean people aren't moving. And when people don't move, they don't do big renovations. Why remodel the kitchen if you're not selling? Why build a deck if you're staying put?

**Morningstar** put it bluntly: "High interest rates have also particularly curtailed discretionary upgrades that homeowners typically fund with financing, while a stagnant housing market has limited the home improvement projects that come with housing turnover" .

---

## What Home Depot Is Doing About It

The company isn't just sitting around waiting for rates to drop. They're making moves.

**They're investing in the "Pro."** That's contractor-speak. Electricians, plumbers, builders—the people who spend serious money. Decker said on the call that "pros who are utilizing our pro ecosystem of capabilities are spending more with us" . They're building out tools, sales support, and delivery options to make it easier for pros to do business with them.

**They're buying up specialty distributors.** Remember SRS Distribution? Home Depot bought them in 2024. In 2025, they added GMS, a building products distributor, for about $5.5 billion . These aren't your local Home Depot stores—they're specialized companies that sell to pros. It's a way to get deeper into the professional market without competing with their own stores.

**They're using AI.** Seriously. Decker mentioned "AI-powered project management tools" that are helping pro customers . It's not sexy, but it's smart. If you can help a contractor manage a whole renovation project through your app, they're going to buy their materials from you.

**They're opening stores.** Fifteen new Home Depot locations in 2026, plus 40-50 new SRS locations . Slow and steady.

---

## The 2026 Outlook: Cautious but Not Gloomy

Here's what Home Depot expects for the year ahead.

**Table 3: Home Depot Fiscal 2026 Guidance**

| **Metric** | **Forecast** |

| :--- | :--- |

| Total Sales Growth | 2.5% to 4.5%  |

| Comparable Sales Growth | Flat to 2.0%  |

| New Stores | Approximately 15  |

| Gross Margin | Approximately 33.1%  |

| Operating Margin | 12.4% to 12.6%  |

| Adjusted Operating Margin | 12.8% to 13.0%  |

| EPS Growth | Flat to 4.0%  |

| Adjusted EPS Growth | Flat to 4.0%  |

Notice they're not projecting a huge rebound. Flat to 2% comps. Flat to 4% earnings growth. That's not a company expecting a boom. That's a company expecting more of the same—cautious consumers, high rates, a stagnant housing market.

But here's the thing: that's actually pretty good compared to what could happen. They're not projecting a crash. They're projecting stability.

**Morgan Stanley** analyst Simeon Gutman wrote Tuesday that the "investment case" for Home Depot "is unchanged" after the report . He said home improvement demand is at a "bottom and risks skewed to the upside" .

Translation: Things aren't getting worse. They might even get better.

---

## What the Market Thinks

Investors liked what they saw. Home Depot stock rose about 4% on Tuesday, hitting $392.20 and moving above a buy point . That's a pretty clear vote of confidence.

The stock is up about 10% so far in 2026 . Not bad for a company that just reported lower profits.

**Why the enthusiasm?** Because Home Depot beat expectations. Because they reaffirmed their guidance. Because they're taking market share even in a tough environment.

**Finimize** put it well: "Home-improvement stocks often trade on whether DIY demand is stabilizing – and Home Depot's positive comps hint the downturn may be easing" .

---

## What This Means for Regular People

Okay, so Home Depot's numbers are out. What does it actually mean for you?

### If You're a Homeowner

You're not alone if you're putting off that big renovation. Millions of people are doing the same thing. High rates and economic uncertainty have everyone hunkering down.

But here's the flip side: your house is getting older every day. That roof isn't getting younger. That water heater isn't getting newer. At some point, the stuff you've been putting off becomes the stuff you can't put off anymore. That's why Home Depot is still seeing people spend more per trip—they're fixing what breaks.

### If You're a Home Depot Shopper

You're probably not going to see any big changes. The stores will keep operating. The orange aprons will keep helping. Maybe you'll notice a few more tools for contractors, a few more delivery options. But mostly, it's business as usual.

### If You're an Investor

This is where it gets interesting. Home Depot is a classic "steady Eddie" stock. They pay a dividend. They've raised it for 16 straight years . They generate cash. They're not going to double overnight, but they're not going to zero either.

The big question is when the housing market turns. When rates drop and people start moving again, that deferred demand for renovations could come roaring back. Home Depot is positioned to capture that.

**Gutman** wrote: "It's all about the eventual housing recovery" . And the Q4 results "support the path to an inflection in home improvement demand" .

---

## What to Watch Next

A couple things to keep an eye on.

**Lowe's reports tomorrow.** They're the other half of the home improvement duopoly. How they did will tell us whether Home Depot's results were just about them or about the whole industry.

**Interest rates.** Everything in housing comes back to rates. If the Fed starts cutting, people start moving. If people start moving, they start renovating. Simple as that.

**The "Pro" business.** Home Depot is betting big on contractors and builders. Watch their SRS business and those specialty distributors. If that part of the business grows, it's a good sign they're winning where it matters.

---

## Frequently Asked Questions

**Q: Did Home Depot have a good quarter?**

A: It depends on how you look at it. Sales and profits were down from last year, but they beat what analysts expected . Comparable sales actually grew a little when you adjust for the calendar. So... solid, not spectacular.

**Q: Why are they raising the dividend by only 1.3%?**

A: Because they're being cautious. Companies hate cutting dividends, so they'd rather raise them a tiny amount they know they can sustain than raise them a lot and risk having to take it back later. The signal is: we're confident, but not that confident.

**Q: What's the yield on Home Depot stock now?**

A: Based on the new $2.33 quarterly dividend and Monday's closing price of $376.99, the annual yield is about 2.47% .

**Q: When is the dividend paid?**

A: March 26, 2026, to shareholders of record on March 12 .

**Q: Why are people spending less at Home Depot?**

A: Two big reasons. First, high interest rates mean fewer people are moving, and fewer moves mean fewer renovations. Second, people are just cautious right now—they're fixing what breaks but not starting big projects .

**Q: What's the outlook for 2026?**

A: Home Depot expects sales growth of 2.5% to 4.5% and earnings per share to be flat to up 4% . That's not a boom forecast, but it's not a bust either.

**Q: How did the stock react?**

A: The stock rose about 4% on Tuesday, hitting $392.20 . Investors liked the earnings beat and the reaffirmed guidance.

**Q: Is Home Depot a good stock to buy?**

A: I can't give investment advice. But analysts seem to think the investment case is intact, and the stock is trading near a buy point . It's a steady dividend payer with a solid business. Whether that fits your portfolio is up to you.

**Q: What's the deal with SRS and GMS?**

A: They're specialty distributors Home Depot has bought to get deeper into the professional construction market. SRS focuses on roofing and building supplies. GMS does drywall, ceilings, and other stuff. It's a way to reach contractors without competing with their own stores.

---

## The Bottom Line

Here's what I keep coming back to.

Home Depot just reported a quarter that was... fine. Not great. Not terrible. Fine. Sales down a little. Profits down a little. But still beating expectations. Still growing market share. Still paying that dividend for the 156th quarter in a row.

The bigger story is what this tells us about the American consumer and the American home. People are staying put. They're not moving. They're not doing big renovations. They're fixing what breaks and waiting to see what happens with rates and the economy.

**CEO Ted Decker** summed it up pretty well: "Underlying demand was relatively stable throughout the year" . That's not exciting. But in a year of uncertainty and housing pressure, stable is actually pretty good.

The question now is what happens next. When rates finally come down—and they will, eventually—that pent-up demand for moves and renovations could turn into real growth. Home Depot is positioning itself to capture that, with investments in the Pro business, in digital tools, and in specialty distributors.

Until then, they'll keep grinding. Keep opening stores. Keep raising that dividend by tiny amounts. Keep serving the customers who walk through the door.

It's not flashy. But it's steady. And sometimes steady is exactly what you want.

---

*Got thoughts on Home Depot's results? Planning that renovation you've been putting off? Drop a comment and let me know.*

The AI Recession Is Coming": Citrini Report Author Lays Out a Chilling Playbook for 2028

"The AI Recession Is Coming": Citrini Report Author Lays Out a Chilling Playbook for 2028

**Published: February 24, 2026**

You know how sometimes you read something that just sticks in your head? Something that makes you look at the world a little differently?

That's what happened this week with a 7,000-word report from a little-known research firm called Citrini. It was labeled a "thought experiment." A hypothetical look at what might happen in 2028 if AI really delivers on its promises.

The market reacted like it was real.

**The Dow dropped 822 points yesterday.** IBM had its worst day since 2000—down 13% in a single session . Software stocks got crushed. Payment companies like Visa and Mastercard fell 4-7% . All because of a hypothetical scenario about something that might happen two years from now .

I talked to **Alap Shah**, the co-author of that report and chief investment officer at Lotus Technology Management, about what he actually thinks will happen—and what regular people should be doing about it. Here's what he told me.

---

## The Short Version

**What happened:** A research firm called Citrini published a 7,000-word "thought experiment" imagining what the economy might look like in June 2028 if AI adoption accelerates faster than anyone expects . The scenario includes a 38% drop in the S&P 500, 10% unemployment, and a cascade of defaults in private credit and mortgages .

**What the market did:** Panicked. IBM dropped 13%—its worst day in 26 years. Datadog, CrowdStrike, and Zscaler all fell more than 9%. Payment stocks got hammered .

**What the author says now:** Alap Shah appeared on Bloomberg TV to clarify that this was always a "what if" exercise, not a prediction . But he also laid out a real playbook for how governments and individuals should prepare—starting with an **AI tax** to cushion the blow .

**Why it matters:** Even if the exact scenario doesn't happen, the underlying logic is hard to dismiss. AI is going to displace jobs. Probably a lot of them. And we're not ready.

---

## The Citrini Scenario: What They Actually Said

First, let's be clear about what this report was and wasn't.

The document, titled **"The 2028 Global Intelligence Crisis,"** was explicitly labeled a "historical thought experiment from the future" . It wasn't a prediction. It was a story designed to make people think about second-order effects.

But it was a very compelling story.

Here's the scenario they laid out for June 2028:

**Table 1: The Citrini "Thought Experiment" Numbers**

| **Metric** | **2028 Scenario** | **What It Means** |

| :--- | :--- | :--- |

| S&P 500 | Down 38% from peak | Wiped out years of gains |

| Unemployment | 10.2% | Depression-era levels |

| Private credit | Collapsing | $2.5 trillion market at risk |

| Prime mortgages | "Cracking at the seams" | Even good borrowers struggling |

| Tax revenue | Falling sharply | Governments can't pay bills |

The logic chain goes like this:

**Step 1:** Companies deploy AI agents that can do the work of humans—coders, analysts, lawyers, project managers. Margins improve. Profits hit records. Wall Street cheers.

**Step 2:** Those displaced workers stop spending money. Consumption—which is 70% of the U.S. economy—starts to shrink.

**Step 3:** Companies respond by investing even more in AI to maintain profits, which displaces even more workers.

**Step 4:** Defaults start piling up. Private credit deals backed by software company revenue go bad. Then mortgages—because if you're a white-collar worker who just lost your job, you can't pay your mortgage, even if you have good credit.

**Step 5:** Tax revenues collapse. Governments can't fund basic services. They start talking about AI taxes or universal basic income, but by then it's too late.

The report called this the **"human intelligence premium"** disappearing. For centuries, human brains were the scarce resource. Now they're not.

---

## The Market Reaction: Why Everyone Panicked

Here's the thing that's fascinating about this. The market didn't treat this as a thought experiment. It treated it as a warning.

**Table 2: Stocks That Got Hit (Feb 23-24, 2026)**

| **Company** | **Drop** | **Why** |

| :--- | :--- | :--- |

| IBM | -13.1% | Anthropic said Claude can optimize COBOL—the code IBM systems run on  |

| Datadog | -9%+ | Monitoring software—if companies cut staff, they need less monitoring |

| CrowdStrike | -9%+ | Same logic |

| Zscaler | -9%+ | Same logic |

| Microsoft | -3.2% | Tech selloff |

| Oracle | -4.6% | Tech selloff |

| Accenture | -6.6% | Consulting—if AI replaces consultants, who needs them? |

| Visa | -4-7% | AI agents might find cheaper payment rails, like stablecoins |

| Mastercard | -4-7% | Same |

| American Express | -4-7% | Same |

| Apollo Global | -5% | Private credit exposure |

| Blue Owl | -3.4% | Private credit exposure |

**Why IBM got crushed:** Anthropic announced that Claude can now optimize COBOL code . COBOL is ancient—it's the programming language that runs most mainframe systems, including a lot of IBM's stuff. If Claude can modernize that code without hiring humans, what happens to IBM's services business? The market decided it didn't want to find out.

**The Kobeissi Letter** put it bluntly on X: "Today is the day AI became dystopian for millions of people" .

---

## The Author's Playbook: What We Should Actually Do

After the selloff, Alap Shah went on Bloomberg TV to clarify and, more importantly, to lay out what he actually thinks should happen.

**His core argument:** Governments need to start thinking about an **AI tax** now, before the crisis hits .

Here's the logic:

**1. The displacement is coming faster than we think.**

Shah sketched out a scenario where **5% of white-collar workers could be cut within 18 months** . That's not 2028. That's late 2027.

**2. Without intervention, consumption collapses.**

White-collar workers aren't just workers—they're consumers. They buy houses, cars, vacations, restaurant meals. If 5% of them lose their jobs, that's a lot of spending that disappears.

**3. Tax revenues fall just when we need them most.**

Fewer workers means less income tax. Less consumption means less sales tax. Governments end up with less money to help the very people who need help.

**4. The solution: tax the winners.**

Shah's proposal: tax the incremental or windfall gains that companies get from AI . Use that money to cushion the transition—retraining, income support, maybe even some form of universal basic income.

**Is this realistic?** Politically, it's a tough sell. Tech companies will fight it. But the logic is hard to dismiss. If AI concentrates wealth while displacing workers, something has to give.

---

## What Other Experts Are Saying

Shah isn't alone in this thinking. A bunch of other voices have been saying similar things.

**The PwC 2026 AI Business Predictions** point to a "sandglass" workforce structure: lots of junior people, lots of senior people, but the middle gets hollowed out . AI handles the mid-level work. That means fewer career ladders for young people to climb.

**Google's internal AI playbook** talks about "AI proficiency" becoming the baseline for every professional . They've seen a 14% increase in lead conversion from AI tools, and their marketing team saved 18,000 hours in 2025 alone . That's great for Google. For the people who used to do that work? Not so much.

**Info-Tech Research Group** found that 92% of organizations lack a corporate-wide AI strategy . Most are stuck in "pilot purgatory"—experimenting but not scaling. That's actually good news in the short term. It means mass displacement isn't happening yet. But it also means companies aren't thinking about the long-term implications.

**The DoorDash founder** quoted in the Citrini report put it well: "We're not just competing with other delivery apps anymore. We're competing with AI agents that will find the cheapest option across every platform simultaneously" . That's a whole different ballgame.

---

## The "SaaSpocalypse" and Why Software Got Hammered

One of the most interesting parts of this whole saga is what it means for software companies.

**The traditional SaaS model:** Charge per user. More users = more revenue.

**The AI problem:** If AI replaces users, who needs the license?

The Citrini report imagines a scenario where AI agents can code, test, deploy, and maintain software with minimal human input. That means companies need fewer developers, fewer IT staff, fewer project managers. And fewer software licenses.

**The paradox:** ServiceNow sells automation software. Their customers use it to automate tasks and cut staff. But if those customers cut too many staff, they might cancel their ServiceNow licenses . It's a weird loop.

This is why software stocks got crushed. The market is starting to realize that the SaaS model might not work in a world where the "user" isn't human.

---

## The Payment Problem: What Happens to Visa and Mastercard?

Another big piece of this is payments.

Right now, Visa and Mastercard make a killing on interchange fees—the 2-3% cut they take every time you swipe a card. Those fees exist because it's a pain to use anything else.

But what if AI agents could find cheaper alternatives?

The Citrini scenario imagines AI agents scanning payment options in real-time and choosing the lowest-cost rail. Sometimes that's a credit card. Sometimes it's a direct bank transfer. Sometimes it's a stablecoin on a low-fee network .

If that happens, the whole payment model breaks down. **Interchange fees compress. Revenue drops. Stock prices fall.**

That's why Visa, Mastercard, and Amex all got hit in the selloff .

---

## The Mortgage Angle: This One's Personal

Here's the part that hits closest to home for most Americans.

The Citrini report imagines a scenario where even **prime mortgage borrowers** start defaulting .

Not because they were irresponsible. Not because they took out loans they couldn't afford. But because their income—the thing that made them "prime" borrowers in the first place—got wiped out by AI .

**The numbers:** There's about **$13 trillion** in residential mortgage debt in the U.S. Most of it is held by people with good jobs. If those jobs disappear, that debt becomes toxic.

The report describes a cascade:

- White-collar layoffs

- Spending stops

- Mortgage payments stop

- Housing prices drop

- More defaults

- Banks get squeezed

- Economy spirals

It's a scary picture. And unlike 2008, it wouldn't be subprime borrowers causing the problem. It would be the people we always thought were safe.

---

## What You Can Actually Do About This

Okay, so the scenario is scary. What do you do about it?

I asked around and pulled together some practical advice from people who think about this stuff.

**Table 3: A Personal AI Playbook**

| **What to Do** | **Why** | **How** |

| :--- | :--- | :--- |

| Diversify your income | If one job disappears, you need others | Side hustle, freelance, investments |

| Learn AI tools | The people who use AI will replace the people who don't | Take a course, experiment with tools |

| Focus on human skills | AI can code; can it lead, empathize, negotiate? | Develop soft skills |

| Pay down debt | If income gets squeezed, less debt is better | Prioritize high-interest debt |

| Build an emergency fund | 6 months of expenses minimum | Automate savings |

| Stay informed | The landscape changes fast | Read, listen, ask questions |

**The Google Cloud COO** put it well: "AI proficiency is the baseline for every professional" . You don't have to be a programmer. But you need to understand what AI can and can't do, and how to use it in your job.

**The PwC report** talks about the rise of the "AI generalist"—someone who knows enough to supervise AI agents across multiple domains . That might be the new career path for a lot of people.

---

## Frequently Asked Questions

**Q: Is the Citrini report predicting an economic collapse?**

A: No. The authors explicitly labeled it a "thought experiment" and a "hypothetical scenario." But they're asking questions that deserve answers.

**Q: Why did the market drop so much if it's just hypothetical?**

A: Because the logic is compelling. Even if the exact 2028 scenario doesn't happen, the underlying forces are real. AI will displace jobs. We're not ready. The market is starting to price that in.

**Q: What's an "AI tax"?**

A: Alap Shah's proposal: tax the windfall profits companies get from AI and use that money to support displaced workers . It's controversial, but it's getting attention.

**Q: Should I sell my tech stocks?**

A: I can't give investment advice. But diversification is always smart. The companies most exposed to AI disruption—software, payments, consulting—might have more volatility ahead.

**Q: What jobs are safest from AI?**

A: Jobs that require physical presence, complex human interaction, or creative leadership. Think construction, healthcare, teaching, management. But even those will change.

**Q: When will this actually happen?**

A: Shah's timeline is sobering: 5% of white-collar jobs could be cut within 18 months . That's not 2028. That's late 2027.

**Q: What's the "human intelligence premium"?**

A: The idea that human brains were a scarce, valuable resource. AI is making them less scarce. That premium is disappearing.

**Q: Is the mortgage scenario realistic?**

A: It's a thought experiment, but the logic is sound. If white-collar workers lose jobs, they stop paying mortgages. Even prime borrowers. That's just math.

**Q: What about universal basic income?**

A: Some people think UBI is the answer. The Citrini scenario imagines governments struggling to fund it after tax revenues collapse. That's the catch—you need the money before the crisis, not after.

**Q: Where can I read the full report?**

A: The original Citrini Research piece is available on Substack. Fair warning: it's 7,000 words and not exactly light reading. But it's worth your time.

---

## The Bottom Line

Here's what I keep coming back to.

The Citrini report is not a prediction. It's a warning. It's a way of thinking about second-order effects that most of us ignore because they're too complicated or too far away.

But the market's reaction tells us something important: **we're all a little scared, and we're not sure what to do about it.**

The selloff in IBM, in software stocks, in payment companies—that's not about one report. That's about a growing realization that the rules are changing. The things that worked for the last 20 years might not work for the next 20.

**Alap Shah's playbook**—tax the winners, cushion the transition—is one approach. It's not perfect. It's not politically easy. But at least it's thinking about solutions, not just problems.

For the rest of us, the playbook is simpler but harder: adapt. Learn the tools. Diversify your income. Pay down debt. Stay flexible.

Because whether the Citrini scenario happens in 2028 or 2032 or never, one thing is certain: the world is changing. And the people who adapt fastest are the ones who'll be okay.

**The Kobeissi Letter** called Monday "the day AI became dystopian for millions of people." That might be overstating it. But it's also not entirely wrong.

We're in for a ride. Buckle up.

---

*Got thoughts on the Citrini report? Scared or skeptical? Drop a comment and let me know. And if you're in a job you think might be at risk, let's talk about what you're doing to prepare.*